Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript May 1, 2024

Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good afternoon, everyone. I’m the operator for today’s call. Thank you for joining today as Emergent discusses their operational and financial results for...